JNJ : Summary for Johnson & Johnson - Yahoo Finance

U.S. Markets closed

Johnson & Johnson (JNJ)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
123.47-0.27 (-0.22%)
At close: 4:02PM EDT
People also watch
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close123.74
Bid123.27 x 200
Ask123.69 x 400
Day's Range123.13 - 123.90
52 Week Range109.32 - 129.00
Avg. Volume6,701,950
Market Cap334.71B
PE Ratio (TTM)20.75
Earnings DateN/A
Dividend & Yield3.20 (2.59%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • The Wall Street Journal22 hours ago

    [$$] Sanofi 1Q Net Profit Rises on Sale of Animal-Health Unit

    French drugmaker Sanofi said 1Q net profit jumped to about $6.2 billion, boosted by the sale of its animal-health business. To revive growth, Sanofi has boosted its research and is seeking to acquire an ...

  • Motley Foolyesterday

    Is Remicade Losing Out to Biosimilars?

    Biosimilars begin to take a small bite out of Johnson & Johnson's top line.

  • Reutersyesterday

    Global med-tech firms, India locked in tussle after stent price sting

    NEW DELHI/MUMBAI, April 28 (Reuters) - A group of global medical-technology companies plans to tell Indian officials next month that any further price control measures would risk future investments and make them less likely to introduce new products in the country, according to an industry source familiar with the matter. The lobbying effort by Abbott Laboratories, Boston Scientific, Johnson & Johnson and others comes after the government of Prime Minister Narendra Modi in February set a price cap for stents - small wire-mesh structures used to treat blocked arteries - slashing prices that patients pay for some devices by about 75 percent.